**Core Concept**
Acute myeloid leukemia (AML) is a heterogeneous group of malignancies characterized by clonal expansion of myeloid blast cells. The prognosis of AML is influenced by various factors, including cytogenetic abnormalities, molecular mutations, and clinical characteristics.

**Why the Correct Answer is Right**
The correct answer is likely **D**. In AML, certain factors are associated with a poor prognosis, such as:

* **Age > 60 years**: Older adults tend to have a higher risk of treatment-related mortality and a lower likelihood of achieving complete remission.
* **High white blood cell count**: A high initial white blood cell count is associated with a higher risk of treatment failure and shorter survival.
* **Cytogenetic abnormalities**: Certain chromosomal abnormalities, such as monosomy 5 or 7, and complex karyotypes, are associated with a poor prognosis.
* **Molecular mutations**: Mutations in genes such as NPM1, FLT3-ITD, and TP53 are associated with a poor prognosis.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not specified, but it may refer to a specific cytogenetic abnormality or molecular mutation that is not inherently poor prognostic. However, without more information, it is difficult to determine why this option would be incorrect.
* **Option B:** This option is not specified, but it may refer to a clinical characteristic or laboratory finding that is not consistently associated with a poor prognosis in AML.
* **Option D:** This option is the correct answer, as it is the one that does not belong to the list of poor prognostic factors in AML.

**Clinical Pearl / High-Yield Fact**
In AML, the presence of a normal karyotype is associated with a better prognosis than abnormal cytogenetics. However, this does not necessarily mean that patients with a normal karyotype have a favorable outcome, as molecular mutations and other factors can still influence prognosis.

**Correct Answer:** D